参考文献/References:
[1] 朱仕逸,张广,亓敬涛,等.经静脉途径治疗脑动静脉畸形研究进展[J].介入放射学杂志,2017,26(12):1147-1150.
[2] 耿悦,王剑,周浩,等.全脑一站式CTA-CTP对脑动静脉畸形的临床价值探讨[J].实用放射学杂志,2016,32(12):1834-1837.
[3] 冯佳良,杨建凯,赵银龙,等.人脑动静脉畸形及贝伐单抗相关作用研究进展[J].河北医药,2017,39(13):2036-2040.
[4] 马琳,石树君.急性脑卒中患者TGFBR2基因多态性与动态血压指数的关联研究[J].重庆医学,2016,45(35):4983-4985.
[5] 余结根,李荣,常微微,等.中国人群转化生长因子-β1基因 T869 C 多态性与原发性高血压相关性的 Meta分析[J].中国临床药理学杂志,2016,32(13):1231-1233.
[6] 郑加永,徐晓敏,夏虹,等.转化生长因子β1及其受体基因多态性与原因不明复发性流产的关系[J].中华妇产科杂志,2017,52(4):261.
[7] 魏健强,李健,薛婷婷,等.转化生长因子β_1及转化生长因子β受体基因多态性与脑动静脉畸形患者脑出血的关系研究[J].实用心脑肺血管病杂志,2016,24(8):39-41.
[8] 张金,郝冬琳,何国平.急性小动脉闭塞性脑卒中病人脑微出血与血清转化生长因子-β_1的相关性研究[J].中西医结合心脑血管病杂志,2016,14(21):2559-2561.
[9] Chen GZ,Ke Y,Qin K,et al.Analysis of the expression of angioarchitecture-related factors in patients with cerebral arteriovenous malformation[J].Chin Med J,2017,130(20):2465-2472.
[10] 王东,张金峰,屈浙,等.颅内动脉瘤和动静脉畸形患者VEGF的表达及与临床特征的关系[J].现代生物医学进展,2017,17(26):167-170.
[11] Hanakita S,Shin M,Koga T,et al.Outcomes of volume-staged radiosurgery for cerebral arteriovenous malformations larger than 20cm3 with more than 3years of follow-up[J].World Neurosurg,2016,87(1):242-249.
[12] 贺迎坤,白卫星,李天晓.经颈内静脉途径治疗复杂破裂脑动静脉畸形[J].中华医学杂志,2017,97(29):2306.
[13] Ren QQ,He M,Zeng YH,et al.Microsurgery for intracranial arteriovenous malformation: Long-term outcomes in 445 patients[J].PLoS One,2017,12(3):e0174325.
[14] Srinivasan VM,Schafer S,Ghali MG,et al.Cone-beam CT angiography(Dyna CT)for intraoperative localization of cerebral arteriovenous malformations[J].J Neurointerv Surg,2016,8(1):69-74.
[15] Tong XZ,Wu J,Cao Y,et al.New predictive model for microsurgical outcome of intracranial arteriovenous malformations: study protocol[J].BMJ Open,2017,7(1):e014063.